Neuromelanin Magnetic Resonance Imaging in Parkinson's Disease and Multiple System Atrophy
暂无分享,去创建一个
Hidekazu Tomimoto | Masayuki Maeda | M. Maeda | H. Tomimoto | Keita Matsuura | Kenichiro Yata | Yoshito Ichiba | Tomoya Yamaguchi | Kenji Kanamaru | K. Matsuura | K. Kanamaru | Kenichiro Yata | Yoshito Ichiba | Tomoya Yamaguchi
[1] A. Graybiel,et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.
[2] A. Graybiel,et al. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.
[3] J. Greenfield,et al. THE BRAIN-STEM LESIONS IN PARKINSONISM , 1953, Journal of neurology, neurosurgery, and psychiatry.
[4] Francesco Federico,et al. Proton magnetic resonance spectroscopy in parkinson's disease and atypical parkinsonian disorders , 1997 .
[5] Paul M. Matthews,et al. MRI characteristics of the substantia nigra in Parkinson's disease: A combined quantitative T1 and DTI study , 2009, NeuroImage.
[6] K. Kashihara,et al. Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD. , 2011, Internal medicine.
[7] J. Yun,et al. Putaminal abnormality on 3-T magnetic resonance imaging in early parkinsonism-predominant multiple system atrophy , 2010, Journal of Neurology.
[8] K. Kashihara,et al. Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson’s disease , 2011, Journal of Clinical Neuroscience.
[9] Klaus Seppi,et al. Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes. , 2010, Neuroimaging clinics of North America.
[10] A J Lees,et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy , 1998, Journal of neurology, neurosurgery, and psychiatry.
[11] Yasuo Terayama,et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease , 2006, Neuroreport.
[12] Dorothee P Auer,et al. T1‐Weighted MRI shows stage‐dependent substantia nigra signal loss in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[13] J. Parisi,et al. Loss of A5 noradrenergic neurons in multiple system atrophy , 2008, Acta Neuropathologica.
[14] F. Tison,et al. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD , 2003, Journal of Neural Transmission.
[15] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[16] P. Yates,et al. PATHOLOGICAL BASIS FOR NEUROTRANSMITTER CHANGES IN PARKINSON'S DISEASE , 1983, Neuropathology and applied neurobiology.
[17] C. Marsden,et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy , 1995, Annals of neurology.
[18] Chandrasekharan Kesavadas,et al. Utility of susceptibility-weighted MRI in differentiating Parkinson’s disease and atypical parkinsonism , 2010, Neuroradiology.
[19] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[20] Susan M. Resnick,et al. Morphometry of the human substantia nigra in ageing and Parkinson’s disease , 2008, Acta Neuropathologica.
[21] P Sandroni,et al. Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.
[22] G. Fenichel,et al. Studies on neuromelanin , 1967, Neurology.
[23] Niall P Quinn,et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. , 2004, Brain : a journal of neurology.
[24] Francesco Fera,et al. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. , 2006, Brain : a journal of neurology.
[25] Francesco Fera,et al. MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease. , 2006, Radiology.
[26] C Kremser,et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD , 2002, Neurology.
[27] Y. Miki,et al. "Hot cross bun" sign in multiple system atrophy with predominant cerebellar ataxia: a comparison between proton density-weighted imaging and T2-weighted imaging. , 2012, European journal of radiology.
[28] N P Quinn,et al. Clinicopathological study of 35 cases of multiple system atrophy. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[29] F. Tison,et al. Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.
[30] C. Good,et al. Differentiation of atypical parkinsonian syndromes with routine MRI , 2000, Neurology.
[31] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[32] D. Graham. On the origin and significance of neuromelanin. , 1979, Archives of pathology & laboratory medicine.